Afrocentric InvestmentJSE:ACT 52 Beneish M-Score is -4.75 as of Jun. 27, 2026. GuruFocus rates JSE:ACT with a GF Score™ of 52/100 and a GF Value™ of R2.09 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 633 Healthcare Providers & Services companies, Afrocentric Investment ranks better than 95.26% on this metric.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Good Sign:
Beneish M-Score -4.75 no higher than -1.78, which implies that the company is unlikely to be a manipulator.
The historical rank and industry rank for Afrocentric Investment's Beneish M-Score or its related term are showing as below:
JSE:ACT'
s Beneish M-Score Range Over the Past 10 Years
Min: -4.75 Med: -2.55 Max: -1.67
Current: -4.75
During the past 13 years, the highest Beneish M-Score of Afrocentric Investment was -1.67. The lowest was -4.75. And the median was -2.55.
Afrocentric Investment Beneish M-Score Related Terms
Afrocentric Investment Beneish M-Score Historical Data
* Premium members only.
The historical data trend for Afrocentric Investment's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JSE:ACT vs HCA, THC, DVA: Beneish M-Score Comparison
For the Medical Care Facilities subindustry, Afrocentric Investment's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Afrocentric Investment Beneish M-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Afrocentric Investment's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Afrocentric Investment for today is based on a combination of the following eight different indices:
M
=
-4.84
+
0.92 * DSRI
+
0.528 * GMI
+
0.404 * AQI
+
0.892 * SGI
+
0.115 * DEPI
=
-4.84
+
0.92 * 0.4141
+
0.528 * 0.9565
+
0.404 * 0.8287
+
0.892 * 1.9395
+
0.115 * 0.5605
-
0.172 * SGAI
+
4.679 * TATA
-
0.327 * LVGI
-
0.172 * 1.3979
+
4.679 * -0.468636
-
0.327 * 1.5187
=
-4.75
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI
=
(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))
/
(Depreciation_t / (Depreciaton_t + PPE_t))
=
(192.324 / (192.324 + 801.995))
/
(392.62 / (392.62 + 745.068))
=
0.193423
/
0.345103
=
0.5605
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA
=
(IncomefromContinuingOperations_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(NetIncome_t - NonOperatingIncome_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(-1274.21 - 0
-
684.903)
/
4180.454
=
-0.468636
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Afrocentric Investment has a M-score of -4.75 suggests that the company is unlikely to be a manipulator.
Afrocentric Investment (JSE:ACT) has a Beneish M-Score of -4.75 as of Jun. 27, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Afrocentric Investment and its competitors. According to the industry distribution chart, Afrocentric Investment ranks #30 out of 633 companies in the Healthcare Providers & Services industry, placing it in the top 4.7%.
Is Afrocentric Investment's Beneish M-Score too high?
Afrocentric Investment's current Beneish M-Score is -4.75. Based on the distribution chart, Afrocentric Investment ranks #30 out of 633 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Afrocentric Investment has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Afrocentric Investment's Beneish M-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Afrocentric Investment ranks #30 out of 633 companies for Beneish M-Score. This places Afrocentric Investment in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Healthcare Providers & Services company?
A good Beneish M-Score depends on the Healthcare Providers & Services industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Afrocentric Investment and its competitors. Afrocentric Investment's current Beneish M-Score is -4.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Afrocentric Investment stock overvalued right now?
Based on GuruFocus' analysis, Afrocentric Investment (JSE:ACT) is currently considered Possible Value Trap. The stock's GF Value™ is R2.09, compared to a current price of R0.79 — trading 62.2% below its estimated fair value. The current Beneish M-Score is -4.75. Afrocentric Investment's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Afrocentric Investment (JSE:ACT), the current Beneish M-Score is -4.75 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Afrocentric Investment (JSE:ACT) Overvalued in 2026?
Based on GuruFocus' analysis, Afrocentric Investment stock appears to be undervalued.
The current stock price of R0.79 is trading 62.2% below its estimated GF Value™ of R2.09.
GuruFocus considers Afrocentric Investment to be Possible Value Trap.
Key valuation signals for JSE:ACT:
Beneish M-Score: -4.75
GF Value™: R2.09 vs. price of R0.79 (62.2% below fair value)
No single metric tells the full story. See the JSE:ACT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Afrocentric Investment Corp Ltd is an investment holding company providing specialised services and products to the public and private healthcare sectors. It focuses on making quality healthcare accessible and affordable to members and beneficiaries, with the principal objective of ensuring the delivery of efficient health management services and the distribution of quality products. Its business segments include Healthcare SA, comprising medical scheme administration and health risk management services; Healthcare Retail, comprising pharmaceutical sales and services; Healthcare Africa, comprising healthcare services outside South Africa in Namibia and Mauritius; and IT-related services predominantly within South Africa. It operates across South Africa, Botswana, Mauritius, and Namibia.
52GF Score
Get the complete analysis for JSE:ACT
Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:ACT has been successfully added to your 
